#Replicon vaccine

[lasseling]

Japanese Doctors Rise Up against Bill Gates’ New Covid ‘Replicon Vaccine’

Thousands of Japanese doctors and university professors have risen up in protest against the government’s rollout of Bill Gates’s deadly new “vaccine” for Covid.

[thefreethoughtprojectcom]

Have you heard about the next generation of "vaccines" that Big Pharma is preparing to unleash upon the public? They're called sa-mRNA vaccines, or "replicon" vaccines, and they've already been approved in Japan.

Read More: https://thefreethoughtproject.com/vaccine-safety-health/replicon-big-pharma-preps-the-next-bioweapon

#TheFreeThoughtProject

[covid-safer-hotties]

Also preserved on our archive (Daily updates)

Meanwhile, covid deniers are in charge of both our major parties here in the states... I wish we could have some kind of simple, reality-based response to misinformation like this.

TOKYO -- A Japanese pharmaceutical firm has revealed that it is considering filing a lawsuit seeking damages from a lawmaker who has been critical about the company's new coronavirus vaccine, describing it as being "like a biological weapon" in a post on X (formerly Twitter).

The replicon vaccine, which is sold by Meiji Seika Pharma Co. under the product name "Kostaive," has been put into practical use in this fall's routine inoculations against COVID-19 for the first time. The distributor is considering demanding compensation from Kazuhiro Haraguchi, a House of Representatives member belonging to the main opposition Constitutional Democratic Party of Japan, claiming that he has defamed the company's reputation by repeatedly expressing disapproval of the drug without scientific evidence.

According to Meiji Seika Pharma and other sources, Haraguchi described the replicon vaccine, which is designed to replicate messenger RNA in cells, as being "like a biological weapon" in a post on his X account. The company sent him a written warning in early October. However, in his campaign bulletin for the Oct. 27 lower house election, Haraguchi wrote, "It is no exaggeration to say that we are being used as guinea pigs when an unknown vaccine is approved only for Japan."

In an opinion released on Oct. 31, Meiji Seika Pharma stated, "We believe that such remarks by a Diet member run the risk of disrupting the foundation of science communication, which is based on objectivity guaranteed by the national government's intervention in medicine and scientific nature, and that they pose a major problem with regard to public health."

The company says that the timing of the lawsuit is "under consideration."

The Mainichi Shimbun asked Haraguchi for comment, but had not received a response as of 5 p.m. on Nov. 1.

(Japanese original by Yoshimi Nakamura, Lifestyle, Science & Environment News Department)

[reportsofawartime]

自粛マスク蛋白マン

@1A48wvlkQc6mVdR

·

13時間

これについてるクソノートが笑えるね。だって、プラセボもクソも、そもそも参加者はどっちも接種者だからね。感染しようがナニをしようが機序的にはいつ死んでもおかしくないのだから、どっちが死んだとかいうこと自体に意味はない。もう治験などできる状態ではない

アーロン大塚

@AaronOtsuka

フォロー

レプリコン臨床試験で５人死亡 ARCT-154 COVID-19 Replicon Vaccine(自己増幅型mRNA)試験データを公開しました。 第3b相試験で注射された患者のうち5人が死亡した。注射された参加者は、研究フェーズ1、2、および3aを組み合わせた最初の投与後に90%の有害事象率(74.5%全身-15.2%の医師の診察が必要)を経験しました。 著者の多くは、ワクチンメーカーであるArcturusRxの正社員です。したがって、研究の結論は偏っている可能性が高い。 ARCT-154は、日本ではすでに成人向けに承認されています。安全性データは、この新しい遺伝子技術が人間にとって安全ではないことを裏付けています。 .https://nature.com/articles/s41467-024-47905-1

[darkmaga-returns]

(RECORDED OCTOBER 28, 2024) via The Spellbreakers Podcast: “We sit down AGAIN with the LEGENDARY James Corbett (corbettreport.com) to discuss the top issues he sees on the horizon, what he makes of this trump great awakening narrative, and some solutions talk.”

Trump 2024, The Great Awakening, and Solutions In The Endtimes - LIVE W/ James Corbett

VIDEO (AND ANY ADS THAT MAY PLAY ON IT) COURTESY OF THE SPELLBREAKERS PODCAST RUMBLE CHANNEL

SHOW NOTES:

Century of Enslavement: The History of The Federal Reserve

How & Why Big Oil Conquered The World

Who Is Bill Gates?

Episode 404 – A Brief History of Hopium

The Strange Story of Peter Thiel | Part 1 | Part 2 | Part 3 (coming soon)

Yahoo/Atlantic story from 2013: What is a ‘False Flag’ Attack — and Was Boston One?

Episode 359 – The Secrets of Silicon Valley: What Big Tech Doesn’t Want You to Know

The Media Matrix | Full Documentary

An Agorist Primer by Samuel Edward Konkin III

Episode 429 – Meet Elon Musk, Technocratic Huckster

All Hail Elon’s Martian Technocracy!

Brzezinski: “Today it is infinitely easier to kill a million people than to control a million people.”

The Globalist’s SECRET Message! (about depopulation)

Milken Institute – Universal Flu Vaccine (C-SPAN 2019)

Replicon: Big Pharma Preps the Next Bioweapon

BBC: Human species ‘may split in two’

[deblala]

The Third Atomic Bomb: Self-replicating RNA vaccines – The Expose

https://expose-news.com/2024/10/29/the-third-atomic-bomb-replicon-vaccines/

[vasilzelenak]

https://www.globalresearch.ca/video-japan-rising-the-new-replicon-self-amplifying-mrna-vaccines/5870414

[lasseling]

Doctors Issue Red Alert over New ‘Replicon’ Covid ‘Vaccines’

Leading doctors in Canada are speaking out to warn the public about new “replicon” self-amplifying Covid mRNA “vaccines” which have been dubbed the “third atomic bomb” by renowned experts in Japan.

[nyantria]

The International Crisis Summit descended on Tokyo last week to warn about the new "replicon" self-amplifying mRNA vaccines that are about to be unleashed like a third atomic bomb upon the population of Japan. James Corbett was there to cover the proceedings, to document the speeches, to participate in a massive rally in the heart of Tokyo against this dangerous new medical intervention, and to lecture sitting members of the Japanese Diet about his bodily sovereignty.

Replicon: Big Pharma Preps the Next Bioweapon

Japan becomes the first (and so far the only) country in the world to approve a self-amplifying mRNA “vaccine”

January 2024 – Japanese Professors’ from “Vaccine Study Group” Unveils “Unprecedented” Side Effects in Press Release

April 2024 – Tens of Thousands Protest WHO’s ‘Supranational Grab Over Global Health’ in Japan

May 2024 – Japan’s Former Minister for Internal Affairs and Communications Apologizes During Today’s Massive Protest Against the WHO

Aug 2024 – Japan’s Largest MSM Broadcaster, NHK, Releases Groundbreaking Feature on mRNA Vaccine Harms

International Crisis Summit

−

インターナショナル・クライシス・サミットは先週、東京に降り立ち、第三の原爆のように日本国民に放たれようとしている新しい「レプリコン」自己増幅型mRNAワクチンについて警告を発した。ジェームズ・コルベットは、その模様を取材し、スピーチを記録し、この危険な新しい医療介入に反対する東京の中心部での大規模な集会に参加し、日本の国会議員に自分の身体主権について講義した。

レプリコン大手製薬会社が次の生物兵器を準備中

日本は世界で初めて（そして今のところ唯一）自己増幅型mRNA "ワクチン "を承認した国になる

2024年1月 「ワクチン研究会」の日本人教授がプレスリリースで「前例のない」副作用を発表

2024年4月 日本で数万人がWHOの「世界の健康に対する超国家的な支配」に抗議する

2024年5月 日本の元総務大臣が今日のWHOに対する大規模な抗議行動で謝罪する

2024年8月 - 日本最大のMSM放送局NHKがmRNAワクチンの害に関する画期的な特集を発表

国際危機サミット

[thefree-online]

The New Self-Amplifying RNA Vaccines Promise to be Double, Triple, Quadruple the Fun!

Karen Hunt Just when you thought you’d heard the last of the Covid vaccines—those mRNA vaccines you’ve come to “know and love” as MIT so endearingly puts it— there’s a new version in town. Welcome to the next generation of self-amplifying Covid vaccines, also known as replicons. No, they aren’t “replicants” like in my favorite […]The New Self-Amplifying RNA Vaccines Promise to be Double, Triple,…

[allthebrazilianpolitics]

Regulators greenlight phase two trials for Brazilian Covid vaccine

Brazilian federal health regulator Anvisa authorized a Covid vaccine developed by research institute Senai Cimatec to advance to phase two trials.

Under the technical name RNA MCTI Cimatec HDT, the vaccine is part of a global plan that includes U.S.-based company HDT Bio Corp and India’s Gennova Biopharmaceuticals. Phase one trials were approved in October of last year and began in January.

The health regulator added that the vaccine is based on self-amplifying RNA replicon (repRNA) technology, capable of encoding the coronavirus spike protein.

“Compared to messenger RNA (mRNA) vaccine platforms, the repRNA platform has the potential to generate more robust immune responses, inducing long-term protective immunity at lower dose levels, with potential for single-dose application,” reads a statement. 

Continue reading.